Upper Tract Urothelial Cancer: Guideline of Guidelines
Savio Domenico Pandolfo,Simone Cilio,Achille Aveta,Zhenjie Wu,Clara Cerrato,Luigi Napolitano,Francesco Lasorsa,Giuseppe Lucarelli,Paolo Verze,Salvatore Siracusano,Carmelo Quattrone,Matteo Ferro,Eugenio Bologna,Riccardo Campi,Francesco Del Giudice,Riccardo Bertolo,Daniele Amparore,Sara Palumbo,Celeste Manfredi,Riccardo Autorino
DOI: https://doi.org/10.3390/cancers16061115
2024-03-12
Cancers
Abstract:Background: Upper tract urothelial carcinoma (UTUC) is a rare disease with a potentially dismal prognosis. We systematically compared international guidelines on UTUC to analyze similitudes and differences among them. Methods: We conducted a search on MEDLINE/PubMed for guidelines related to UTUC from 2010 to the present. In addition, we manually explored the websites of urological and oncological societies and journals to identify pertinent guidelines. We also assessed recommendations from the International Bladder Cancer Network, the Canadian Urological Association, the European Society for Medical Oncology, and the International Consultation on Bladder Cancer, considering their expertise and experience in the field. Results: Among all the sources, only the American Urologist Association (AUA), European Association of Urology (EAU), and the National Comprehensive Cancer Network (NCCN) guidelines specifically report data on diagnosis, treatment, and follow-up of UTUC. Current analysis reveals several differences between all three sources on diagnostic work-up, patient management, and follow-up. Among all, AUA and EAU guidelines show more detailed indications. Conclusions: Despite the growing incidence of UTUC, only AUA, EAU, and NCCN guidelines deal with this cancer. Our research depicted high variability in reporting recommendations and opinions. In this regard, we encourage further higher-quality research to gain evidence creating higher grade consensus between guidelines.
oncology